As we have informed here NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announced that it has
Tags :Marc Hanslin
BKW enables pension funds to take out minority stakes in nine wind farms creating space for investments in renewable energies. The international energy and infrastructure company announced that it entered into a contract with Pensionskasse
ZF Friedrichshafen, a global technology company in powertrain and suspension engineering as well as active and passive safety technology, enters into an asset deal for the acquisition of the specialized adhesive films technology for side
Kohlberg Kravis Roberts & Co (KKR), a global investment firm, and Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company, have entered into an agreement where KKR will acquire Biosynth Carbosynth
Crown Holdings, the company specializing in the designing, manufacturing, and sale of packaging products and equipment for consumer and industrial products, has completed the previously announced sale of its European Tinplate business to KPS Capital
Transocean entered into an equity distribution agreement with Jefferies. Pursuant to the terms of the agreement, Transocean may offer and sell its shares, par value CHF 0.10 per share, from time to time through Jefferies, as
Homburger acted as Swiss counsel to ARYZTA in connection with the transaction. The team was led by partner Claude Lambert (Corporate / M&A - pictured) and comprised associates Marc Hanslin (Corporate / M&A) and David
Homburger acted as Swiss counsel to Picanol in connection with the transaction. The team comprised partner Dieter Gericke (pictured) and associate Marc Hanslin (both Corporate / M&A). Stibbe BV/SRL (Jan Peeters) acted as Belgian
The team was led by associate Marc Hanslin (Corporate | M&A - pictured) and included associates Jeremy Reichlin (Data Protection/Privacy) and Kirsten Schmidt (IP/IT and Data Protection/Privacy).
The team also advised on Durfy's CHF 250 m equity investment commitment in the context of the planned CHF 700 m rights offering
